Dhampur Bio Organics Limited (DBOL)
₹140.73 -2.30% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Dhampur Bio's revenue was ₹919 Cr (+74.6% year on year, +70.1% on the previous quarter), and net profit ₹36.8 Cr (against a loss a year earlier); the operating margin was 1.0%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹919 | +74.6% | +70.1% |
| Operating profit | ₹8.9 | +794.0% | -90.6% |
| Net profit | ₹36.8 | from loss | -20.0% |
| EPS (₹) | 5.59 | from loss | -19.8% |
| Operating margin | 1.0% | — | — |
DBOL delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 51.81% of the DBOL shares traded on NSE were taken to delivery, against the stock's own 20-session average of 49.75%. That is close to its usual level. Volume was 0.5 times its average, well below normal.
Delivery in the last 5 sessions: 39.9% · 52.8% · 41.4% · 41.9% · 51.8%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Dhampur Bio Organics Limited has announced internal promotions within its Senior Management Personnel effective October 01, 2026. Mr. Pankaj Agarwal has been elevated from Chief General Manager to Vice President - Finance and Accounts, bringing over 37 years of finance experience with the company. Additionally, Mr. Vinamra Agarwal has been promoted from General Manager to Vice President - Sales and Marketing (Dhampure), having led branded sugar sales across retail and modern trade since 2020. These leadership elevations are internal reorganizations and do not introduce new external management.
- Mr. Pankaj Agarwal promoted to Vice President - Finance and Accounts effective October 01, 2026
- Mr. Vinamra Agarwal elevated to Vice President - Sales & Marketing (Dhampure) effective October 01, 2026
- Mr. Pankaj Agarwal has over 37 years of experience and has been with the company's permanent workforce since May 1993
- Mr. Vinamra Agarwal has over two decades of sales experience and has headed branded sugar sales since 2020
CARE Ratings has reaffirmed Dhampur Bio Organics' long-term bank facilities rating at 'CARE BBB+' while revising the outlook from 'Stable' to 'Positive', alongside reaffirming 'CARE A2' for short-term facilities. The outlook upgrade is driven by substantial debt reduction following the ₹305 crore slump sale of the red-rot affected Meerganj unit in June 2026. The company utilized proceeds to prepay ₹165 crore in debt between April and July 2026, bringing long-term debt down from ₹290 crore to ₹125 crore. Net leverage is projected to moderate to under 5.5x by FY27-end compared to 7.9x in FY26.
- CARE Ratings revised DBOL's rating outlook to Positive from Stable on ₹987.05 Cr long-term bank facilities (rated 'CARE BBB+').
- Short-term bank facilities of ₹75.00 Cr reaffirmed at 'CARE A2', with total rated facilities declining to ₹1,062.05 Cr.
- Long-term debt reduced by ₹165 Cr to ₹125 Cr as of July 31, 2026 (down from ₹290 Cr as of March 31, 2026) using Meerganj unit sale proceeds of ₹305 Cr.
- Net leverage expected to decline to less than 5.5x in FY27 (vs 7.9x in FY26) with interest coverage improving to ~3x (vs 2.1x in FY26).
Dhampur Bio Organics Limited (DBOL) has confirmed the remittance of its final dividend for FY 2025-26. The dividend of ₹1.50 per share (15% of face value) was approved at the AGM on July 24, 2026, and credited to eligible shareholders on August 1, 2026. Based on the TTM EPS of ₹3.80, this represents a payout ratio of approximately 39.5%. The record date for determining eligibility was July 17, 2026.
- Final dividend of ₹1.50 per equity share of ₹10 face value declared for FY 2025-26
- Record date for eligibility was July 17, 2026
- Dividend payment/credit date was August 1, 2026, via NACH
- TDS deducted on gross dividend amounts exceeding ₹10,000
- Dividend yield stands at approximately 1.25% based on the current price of ₹120.3
Mr. Lalit Dalal has resigned from his position as Vice President - Finance and Accounts at Dhampur Bio Organics Limited (DBOL), effective July 31, 2026. The resignation is to pursue external career opportunities. This management change occurs in a company with a market capitalization of ‡712 Cr and a significant debt position of ‡1,060 Cr. While not a Board-level exit, the VP of Finance is a critical role for managing the company's 1.03 debt-to-equity ratio and cyclical cash flows.
- Mr. Lalit Dalal resigned as Vice President - Finance and Accounts effective July 31, 2026.
- The resignation was tendered on July 31, 2026, to pursue career opportunities outside the organization.
- The company operates with a high debt of ‡1,060 Cr against a net worth of ‡1,029 Cr.
- DBOL reported a TTM revenue of ‡2,110 Cr with an operating profit margin of 6.2%.
Dhampur Bio Organics Limited (DBOL) has announced the successful passage of all 11 resolutions at its 6th Annual General Meeting held on July 24, 2026. Shareholders approved a final dividend of ₹1.50 per equity share (15%) for FY26. Key leadership decisions included the re-appointment and re-designation of Gautam Goel as Chairman and CEO with 99.99% favorable votes. While promoter participation was high at 99.7%, public institutional participation remained low at 4.93%.
- Final dividend of ₹1.50 per equity share (15% of face value) approved for FY26.
- Re-appointment of Gautam Goel as Chairman and CEO passed with 99.99% of valid votes cast in favor.
- M/s Mittal Gupta & Company re-appointed as Statutory Auditors for a second 5-year term.
- Remuneration revisions for General Managers Maayashree Goel and Meerashree Goel approved with 99.89% support.
- Total of 11 resolutions passed, including amendments to the Articles of Association via a new Article 125A.
Dhampur Bio Organics Limited (DBOL) concluded its 6th Annual General Meeting on July 24, 2026. Shareholders approved a final dividend of Rs. 1.50 per equity share (15%) for FY26. Key management updates included the re-designation of Gautam Goel as Chairman and CEO and the re-appointment of statutory auditors for a second five-year term. The Chairman also confirmed the completion of the Meerganj unit sale, a strategic move to streamline operations.
- Approved a final dividend of Rs. 1.50 per equity share (15%) for the financial year ended March 31, 2026
- Re-appointed M/s Mittal Gupta & Company as Statutory Auditors for a second term of 5 years
- Confirmed the completion of the Meerganj unit sale on a slump sale basis to optimize the asset portfolio
- Re-designated Gautam Goel as Chairman and Chief Executive Officer via a special resolution
- Company reported TTM revenue of Rs 2,110 Cr and a PAT of Rs 28 Cr as per the financial context
Dhampur Bio Organics Limited (DBOL) reported a significant strengthening of its balance sheet in its Q1FY27 investor presentation. Following the sale of its Meerganj unit on June 18, 2026, the company repaid ₹93 Cr of long-term loans during the quarter. This repayment reduced outstanding long-term debt to ₹124 Cr, down from ₹290 Cr in March 2026. Consequently, the long-term debt-to-equity ratio improved to 0.18x from 0.28x, while operations are now consolidated into two integrated facilities with a total crushing capacity of 20,500 TCD.
- Repaid ₹93 Cr of long-term loans during Q1 FY27, representing ~11.3% of current market cap.
- Long-term debt-to-equity ratio improved significantly to 0.18x as of June 30, 2026.
- Completed the strategic sale of the Meerganj Unit on June 18, 2026.
- Consolidated sugarcane crushing capacity stands at 20,500 TCD across two integrated plants.
- Maintained potable liquor capacity at 8.0 million cases per year to focus on value-added spirits.
Dhampur Bio Organics Limited (DBOL) reported a consolidated PAT of ₹38.40 Cr for Q1 FY27, a significant turnaround from a loss of ₹19.37 Cr in the previous year's quarter. This profit was primarily driven by a one-time gain of ₹63.89 Cr from the sale of its Meerganj unit, completed on June 18, 2026. Excluding this, the company recorded a loss of ₹16.15 Cr from continuing operations before tax. Revenue from operations grew 19.2% YoY to ₹939.55 Cr, while the board opted not to declare an interim dividend.
- Reported a consolidated PAT of ₹38.40 Cr for Q1 FY27, compared to a loss of ₹19.37 Cr in Q1 FY26.
- Recognized a one-time gain of ₹63.89 Cr from the divestment of the Meerganj unit.
- Revenue from operations increased to ₹939.55 Cr, representing approximately 44.5% of the TTM revenue.
- Loss before tax from continuing operations stood at ₹16.15 Cr, showing marginal improvement from a ₹17.50 Cr loss YoY.
- Appointed M/s Grant Thornton Bharat LLP as Internal Auditor for the financial year 2026-27.
Dhampur Bio Organics Limited (DBOL) reported a total net profit of Rs 38.40 Cr for Q1 FY27, a sharp recovery from a loss of Rs 19.37 Cr in Q1 FY26. This turnaround was primarily driven by a one-time gain of Rs 63.89 Cr from the sale of the Meerganj undertaking, which was completed on June 18, 2026. However, the core 'Continuing Operations' remained loss-making, posting a net loss of Rs 12.14 Cr despite a 19.2% YoY increase in revenue to Rs 939.55 Cr. The board opted not to declare an interim dividend for the period.
- Total Net Profit of Rs 38.40 Cr in Q1 FY27 vs a loss of Rs 19.37 Cr in Q1 FY26.
- One-time gain of Rs 63.89 Cr realized from the divestment of the Meerganj unit.
- Revenue from continuing operations grew 19.2% YoY to Rs 939.55 Cr.
- Loss from continuing operations widened slightly to Rs 12.14 Cr from Rs 11.46 Cr YoY.
- Excise duty on sale of goods increased 49% YoY to Rs 385.67 Cr.
Dhampur Bio Organics Limited (DBOL) has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The company's Registrar and Share Transfer Agent, Alankit Assignments Limited, confirmed that for the quarter ended June 30, 2026, there are no shares held in physical form. This is a routine administrative filing required by SEBI to monitor the dematerialization status of securities. The filing indicates full compliance with depository regulations and has no impact on the company's financial performance.
- Compliance certificate issued for the quarter ended June 30, 2026
- Confirmation received from Registrar and Share Transfer Agent, Alankit Assignments Limited, dated July 1, 2026
- Official confirmation that 0 shares are held in physical form within the company
- Filing submitted to exchanges on July 10, 2026, in accordance with SEBI timelines
Dhampur Bio Organics Limited (DBOL) has completed the acquisition of a 74% stake in DBION Private Limited (formerly Sonitron Chemicals Private Limited). The company acquired 7,400 equity shares at a face value of Rs 10 each, totaling a nominal consideration of Rs 74,000. This acquisition is part of a Joint Venture Agreement with Orgonew Private Limited. While DBION is now a subsidiary, the transaction value is negligible compared to DBOL's TTM revenue of Rs 2,110 Cr.
- Acquired 7,400 equity shares representing 74% of the paid-up capital of DBION Private Limited
- Total transaction value is a nominal Rs 74,000 at Rs 10 per share
- DBION Private Limited (formerly Sonitron Chemicals) is now a subsidiary and a Joint Venture entity
- The acquisition follows a Joint Venture Agreement previously entered into with Orgonew Private Limited
Dhampur Bio Organics Limited (DBOL) has convened its 6th Annual General Meeting (AGM) for July 24, 2026. The board has recommended a final dividend of ₹1.50 per share (15%) for FY26, representing a yield of approximately 1.3% at current prices. Key agenda items include the re-designation of Mr. Gautam Goel as Executive Chairman and CEO, and the removal of statutory ceilings on gratuity payments for executive directors. Additionally, the company is seeking approval for a remuneration increase for two General Managers to ₹5,00,000 per month each.
- Final dividend of ₹1.50 per equity share (15%) recommended for the financial year ended March 31, 2026
- Re-designation of Mr. Gautam Goel from MD & CEO to Executive Chairman & CEO effective May 31, 2026
- Proposed basic salary of ₹5,00,000 per month for Ms. Maayashree Goel and Ms. Meerashree Goel (GMs - Management Team)
- Commission of ₹12,00,000 each to be paid to all Non-Executive Directors for FY25-26
- Re-appointment of M/s Mittal Gupta & Company as Statutory Auditors for a second 5-year term until 2032
Dhampur Bio Organics Limited (DBOL) has announced the resignation of Mr. Santosh Mani, Vice President - Operations (Speciality Sugar Packaging), effective June 30, 2026. The resignation, cited for personal reasons, was tendered on May 16, 2026, providing a significant transition period. As a company with TTM revenue of ₹2,110 Cr and a market cap of ₹813 Cr, this change affects a specific operational vertical rather than the core leadership. The company continues to focus on its broader expansion in ethanol and country liquor segments.
- Mr. Santosh Mani resigned from his position as VP - Operations (Speciality Sugar Packaging) effective June 30, 2026.
- The resignation letter was submitted on May 16, 2026, allowing for a transition period of approximately 45 days.
- DBOL maintains a large-scale operation with TTM revenue of ₹2,110 Cr and crushing capacity of 29,500 TCD.
- The company recently reported a strong Mar 2026 quarter with a net profit of ₹46.0 Cr compared to a loss in the previous year's Sep/Jun quarters.
Dhampur Bio Organics Limited (DBOL) has announced the closure of its trading window for insiders starting July 1, 2026. This move is a standard regulatory requirement under SEBI's Insider Trading regulations ahead of the release of financial results for the quarter ending June 30, 2026. The window will remain closed until 48 hours after the results are officially declared. The company will announce the specific date for the board meeting to approve these results in a separate notification.
- Trading window closure starts on July 1, 2026, for all designated persons.
- Closure pertains to the unaudited financial results for the quarter ended June 30, 2026.
- The window will reopen 48 hours after the financial results are made public.
- Board meeting date for result consideration is yet to be announced.
Dhampur Bio Organics Limited (DBOL) has finalized the divestment of its Meerganj sugar unit to Forever Global Enterprises Limited. The transaction was completed on June 18, 2026, for a total purchase consideration of Rs 305 Crores. This slump sale follows the initial Business Transfer Agreement signed in April 2026. The company has confirmed the receipt of funds and the registration of the conveyance deed.
- Successfully completed the slump sale of the Meerganj Unit in Bareilly, Uttar Pradesh.
- Received a total purchase consideration of Rs 305 Crores from Forever Global Enterprises Limited.
- The sale was executed as a going concern, including the registration of the conveyance deed.
- Transaction finalized within two months of the initial board approval on April 20, 2026.
Financial Performance
Revenue Growth by Segment
Total revenue grew 15.0% YoY to INR 2,714.40 Cr in FY25. Segmental growth in H1FY26 showed Sugar up 13.44%, Country Liquor up 50.75%, and Bio-Fuel & Spirits up 65.81% YoY. In FY25, Country Liquor volumes specifically grew by 55.63%.
Geographic Revenue Split
Not disclosed in available documents; however, operations are concentrated in Western-Central Uttar Pradesh (Asmoli, Mansurpur, and Meerganj).
Profitability Margins
Net profit margin declined from 1.92% in FY24 to 0.45% in FY25. H1FY26 PAT margin was negative at -2.16% (INR -34.90 Cr) compared to -1.96% in Q2FY25, driven by lower margins in Sugar and Bio-Fuel segments.
EBITDA Margin
EBITDA margin stood at 5.29% in FY25, down from 6.63% in FY24. H1FY26 EBITDA margin further deteriorated to -0.76% (INR 12.20 Cr) due to lower cane availability and pest infestation impacting recovery rates.
Capital Expenditure
The company is undertaking a minor capex of INR 60 Cr for converting its molasses-based distillery to a dual-feed (molasses and grain) facility. This is financed via a INR 42 Cr term loan and INR 18 Cr internal accruals.
Credit Rating & Borrowing
CARE Ratings maintains a 'Stable' outlook. Borrowing includes a INR 42 Cr term loan eligible for a 50% interest subvention scheme from the government. Interest coverage ratio deteriorated from 4.99x in FY23 to 2.76x in FY24, and further to 2.14x in FY25.
Operational Drivers
Raw Materials
Sugarcane (primary), Grain (secondary for dual-feed distillery), and Molasses (B-Heavy, C-Heavy, and Syrup). Raw materials, excise, and inventory changes accounted for 82.42% of revenue (INR 2,237.10 Cr) in FY25.
Import Sources
Sourced locally from farmers in the catchment areas of Central and Western Uttar Pradesh (UP).
Key Suppliers
Procured from local sugarcane farmers through proactive farmer engagement and development programs in the UP region.
Capacity Expansion
Crushing capacity increased from 22,000 TCD to 29,500 TCD as of March 31, 2024. Country liquor capacity expanded from 4.2 million cases to 8 million cases per annum in FY25. Distillery capacity stands at 312.5 KLPD.
Raw Material Costs
Raw material costs are dictated by the State Advised Price (SAP) set by the Government of UP. Costs are impacted by recovery rates, which fell from 10.99% in 9MFY24 to 10.42% in 9MFY25 due to red rot infestation.
Manufacturing Efficiency
Gross recovery rate was 10.42% in 9MFY25. Efficiency is being targeted through debottlenecking initiatives and the commissioning of additional units in Asmoli (9000 to 12500 TCD) and Meerganj (5000 to 9000 TCD).
Logistics & Distribution
Not specifically disclosed as a percentage, but the company operates three integrated plants to minimize internal transport costs between crushing and distillery units.
Strategic Growth
Expected Growth Rate
16.73%
Growth Strategy
Growth will be driven by the expansion of the country liquor segment (capacity doubled to 8 million cases), the conversion of the Asmoli distillery to a dual-feed facility to allow grain-based ethanol production, and increasing sugar crushing capacity to 29,500 TCD to capture higher market volumes.
Products & Services
Refined sugar, sulphitation sugar, pharma-grade sugar, ethanol, country liquor, and 95.5 MW of renewable power.
Brand Portfolio
Dhampur Bio Organics (DBO).
New Products/Services
Grain-based ethanol production via the new dual-feed facility expected to contribute incrementally to the Bio-Fuel segment from Q3FY25.
Market Expansion
Focusing on the country liquor market in Uttar Pradesh and expanding ethanol supply to Oil Marketing Companies (OMCs) under the national blending program.
Market Share & Ranking
Not disclosed in percentage terms, but identified as a leading Indian producer of ethanol and sulphur-free sugar.
External Factors
Industry Trends
The industry is shifting toward a biofuel-heavy model. The government's 20% ethanol blending target is a key driver, though current restrictions on B-heavy molasses diversion have temporarily slowed this transition.
Competitive Landscape
Competes with other UP-based mills; dynamics are governed by state-mandated cane prices (SAP) and central-mandated sugar quotas.
Competitive Moat
Moat is built on forward integration (Sugar-Distillery-Cogeneration) which cushions cyclicality. The 65-year experience of promoters (VK Goel) and established farmer relationships provide a durable operational advantage.
Macro Economic Sensitivity
Highly sensitive to inflation in the Wholesale Price Index (WPI) as sugar is an essential commodity, leading to government price interventions.
Consumer Behavior
Increasing demand for branded, sulphur-free, and pharma-grade sugar is driving a shift toward value-added sugar products.
Geopolitical Risks
Minimal direct impact due to domestic focus, but global sugar price fluctuations influence government export quota policies.
Regulatory & Governance
Industry Regulations
Operations are heavily regulated by the Essential Commodities Act, State Advised Price (SAP) for cane, and government-allocated monthly sugar sale quotas.
Environmental Compliance
Focus on eco-friendly practices and renewable energy generation (95.5 MW) from sugar by-products.
Taxation Policy Impact
Effective tax rate not explicitly stated, but the company reported a tax credit/adjustment leading to a PAT of INR 12.09 Cr despite lower PBT in FY25.
Risk Analysis
Key Uncertainties
Agro-climatic risks (pest infestation) and sudden changes in government policy regarding ethanol diversion or sugar exports could impact margins by 2-4%.
Geographic Concentration Risk
100% of manufacturing assets are located in Uttar Pradesh, making the company highly vulnerable to state-specific policy changes and regional weather patterns.
Third Party Dependencies
High dependency on the Government of UP for cane pricing and the Central Government for sugar sales quotas and ethanol pricing.
Technology Obsolescence Risk
Low risk in core sugar; however, the company is proactively upgrading to dual-feed distillery technology to avoid obsolescence of molasses-only plants.
Credit & Counterparty Risk
Receivables increased from INR 87.53 Cr to INR 96 Cr in FY25. Current ratio is 1.12x, indicating tight but manageable liquidity.